SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-007049
Filing Date
2017-09-13
Accepted
2017-09-13 16:02:33
Documents
51
Period of Report
2017-07-31

Document Format Files

Seq Description Document Type Size
1 10-Q bpmx-20170731x10q.htm 10-Q 1602637
2 EX-31.1 bpmx-20170731ex311492107.htm EX-31.1 19297
3 EX-31.2 bpmx-20170731ex3123e3e35.htm EX-31.2 19304
4 EX-32.1 bpmx-20170731ex3214b57ec.htm EX-32.1 11490
  Complete submission text file 0001558370-17-007049.txt   5255195

Data Files

Seq Description Document Type Size
5 EX-101.INS bpmx-20170731.xml EX-101.INS 999668
6 EX-101.SCH bpmx-20170731.xsd EX-101.SCH 32640
7 EX-101.CAL bpmx-20170731_cal.xml EX-101.CAL 33124
8 EX-101.DEF bpmx-20170731_def.xml EX-101.DEF 138804
9 EX-101.LAB bpmx-20170731_lab.xml EX-101.LAB 304323
10 EX-101.PRE bpmx-20170731_pre.xml EX-101.PRE 261384
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 001-37411 | Film No.: 171083222
SIC: 2834 Pharmaceutical Preparations